INSIGHT 2019: Accept, Connect, Embody: A Psychedelic Therapy Framework - Dr. Rosalind Watts
Dr. Rosalind Watts | Clinical psychologist, Psychedelic Research Group at Imperial College London.
https://insight-conference.eu/speaker/rosalind-watts/
This presentation outlines the therapy model currently used in the Imperial College London Psilocybin for Depression Study. The development and ongoing use of the ‘ACE’ (Accept, Connect, Embody) model will be described, including case material. This model is based on the ‘Psychological Flexibility Model’ , and the approach itself is very flexible. The rationale for keeping psychedelic therapy non-directive will be discussed.
---------------------
We are a non-profit organisation - but you can support our work with a donation! With your tax-deductible donation we can achieve our goals and visions. Every euro or dollar you donate will fund a project or researcher who is committed to safe and legal therapies, harm reduction and the development of the European health system. Please indicate "Watts Video" as the intended purpose.
Link: https://mind-foundation.org/donate
--------------------
Dr Rosalind Watts is the clinical lead of the Imperial College London Psilocybin for Depression study. She trained as a clinical psychologist and practised psychotherapy for 6 years before joining the Imperial Psychedelic Research Centre (run by Dr Robin Carhart Harris and Professor David Nutt) as a therapist ‘trip sitter’. She has developed a psychedelic therapy model ‘Accept, Connect, Embody’, and a psychometric measure of ‘connectedness’- which her qualitative research identified as a potential mechanism of therapeutic change in psychedelic approaches. Rosalind co-facilitates a monthly integration group for people who are attending psychedelic ceremonies for therapeutic purposes.
Видео INSIGHT 2019: Accept, Connect, Embody: A Psychedelic Therapy Framework - Dr. Rosalind Watts канала MIND Foundation
https://insight-conference.eu/speaker/rosalind-watts/
This presentation outlines the therapy model currently used in the Imperial College London Psilocybin for Depression Study. The development and ongoing use of the ‘ACE’ (Accept, Connect, Embody) model will be described, including case material. This model is based on the ‘Psychological Flexibility Model’ , and the approach itself is very flexible. The rationale for keeping psychedelic therapy non-directive will be discussed.
---------------------
We are a non-profit organisation - but you can support our work with a donation! With your tax-deductible donation we can achieve our goals and visions. Every euro or dollar you donate will fund a project or researcher who is committed to safe and legal therapies, harm reduction and the development of the European health system. Please indicate "Watts Video" as the intended purpose.
Link: https://mind-foundation.org/donate
--------------------
Dr Rosalind Watts is the clinical lead of the Imperial College London Psilocybin for Depression study. She trained as a clinical psychologist and practised psychotherapy for 6 years before joining the Imperial Psychedelic Research Centre (run by Dr Robin Carhart Harris and Professor David Nutt) as a therapist ‘trip sitter’. She has developed a psychedelic therapy model ‘Accept, Connect, Embody’, and a psychometric measure of ‘connectedness’- which her qualitative research identified as a potential mechanism of therapeutic change in psychedelic approaches. Rosalind co-facilitates a monthly integration group for people who are attending psychedelic ceremonies for therapeutic purposes.
Видео INSIGHT 2019: Accept, Connect, Embody: A Psychedelic Therapy Framework - Dr. Rosalind Watts канала MIND Foundation
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Implementing the psychedelic experience in trauma therapy (Rougemont-Bücking)INSIGHT 2019: Is a rational & evidence-based enculturation of the psychedelic experience possible?Horizons 2019: ROSALIND WATTS, Ph.D. & ASHLEIGH MURPHY-BEINER "Psilocybin for Depression"Can psychedelics change your political opinion? An online discussionPsychedelic Research and Therapy 101: An Introductory WebinarKeynote ACES to Assets 2019 – Dr Gabor Maté – Understanding addiction as a result of traumaRosalind Watts: The Hexaflex as an Adjunct to Psychedelic TherapyVaporization or intramuscular injection of synthetic 5-methoxy-N,N-dimethyltryptamine (Uthaug)Phenomenology of the ketamine experience (Gold, Wells)Microdosing Psychedelics: Characteristics and Correlates (Petranker)INSIGHT 2019: A new approach to treating depression; a non-profit’s role in approval for psilocybin.36C3 - Psychedelic Medicine - Hacking Psychiatry?!Michael Causton - Dissolving Childhood Trauma Through Psychedelic TherapyINSIGHT 2019: Psilocybin-Assisted Treatment of Alcohol Use Disorder (Nielson)Integration Psychotherapy (Gorman)The Beckley-Imperial Psychedelic Research Program - David NuttChristopher Timmermann - The Neurophenomenology of the DMT StateResearching Psilocybin's Effects on Depression - Dr. Rosalind WattsHow do psychedelic drugs work on the brain?Advice for People Who Don't Have Access to Psychedelic Therapy